437 related articles for article (PubMed ID: 14748812)
1. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.
Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
Eur J Clin Pharmacol; 2006 Mar; 62(3):185-94. PubMed ID: 16425056
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
Barr J; Zomorodi K; Bertaccini EJ; Shafer SL; Geller E
Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
[TBL] [Abstract][Full Text] [Related]
6. Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review.
Tse AHW; Ling L; Lee A; Joynt GM
Clin Ther; 2018 Sep; 40(9):1598-1615.e2. PubMed ID: 30173953
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective.
Swart EL; van Schijndel RJ; van Loenen AC; Thijs LG
Crit Care Med; 1999 Aug; 27(8):1461-5. PubMed ID: 10470750
[TBL] [Abstract][Full Text] [Related]
8. Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis.
Kos MK; Miksić M; Jovanović M; Roškar R; Grosek Š; Grabnar I
Eur J Pharm Sci; 2020 Jan; 141():105095. PubMed ID: 31626965
[TBL] [Abstract][Full Text] [Related]
9. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.
McCollam JS; O'Neil MG; Norcross ED; Byrne TK; Reeves ST
Crit Care Med; 1999 Nov; 27(11):2454-8. PubMed ID: 10579264
[TBL] [Abstract][Full Text] [Related]
10. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting.
Zomorodi K; Donner A; Somma J; Barr J; Sladen R; Ramsay J; Geller E; Shafer SL
Anesthesiology; 1998 Dec; 89(6):1418-29. PubMed ID: 9856717
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
[TBL] [Abstract][Full Text] [Related]
13. A cost analysis of enterally administered lorazepam in the pediatric intensive care unit.
Lugo RA; Chester EA; Cash J; Grant MJ; Vernon DD
Crit Care Med; 1999 Feb; 27(2):417-21. PubMed ID: 10075070
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of midazolam in critically ill pediatric patients.
Nahara MC; McMorrow J; Jones PR; Anglin D; Rosenberg R
Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):219-21. PubMed ID: 11420893
[TBL] [Abstract][Full Text] [Related]
15. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
[TBL] [Abstract][Full Text] [Related]
16. Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost.
Cernaianu AC; DelRossi AJ; Flum DR; Vassilidze TV; Ross SE; Cilley JH; Grosso MA; Boysen PG
Crit Care Med; 1996 Feb; 24(2):222-8. PubMed ID: 8605792
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation.
Stewart R; Perez R; Musial B; Lukens C; Adjepong YA; Manthous CA
Ann Am Thorac Soc; 2016 Feb; 13(2):248-52. PubMed ID: 26799430
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.
Peeters MY; Prins SA; Knibbe CA; Dejongh J; Mathôt RA; Warris C; van Schaik RH; Tibboel D; Danhof M
Anesthesiology; 2006 Dec; 105(6):1135-46. PubMed ID: 17122576
[TBL] [Abstract][Full Text] [Related]
19. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
Horinek EL; Kiser TH; Fish DN; MacLaren R
Ann Pharmacother; 2009 Dec; 43(12):1964-71. PubMed ID: 19920159
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
